Analytical Data
-
Gene name
MGC16186
- Application
-
Alternative Names
DPY30 domain-containing protein 2
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A0A0MRQ7
-
Expression Region
1-177 aa
-
AA Sequence
METNYLKRCFGNCLAQALAEVAKVRPSDPIEYLAHWLYHYRKTAKAKEENREKKIHLQEEYDSSLKEMEMTEMLKQEEYQIQQNCEKCHKELTSETVSTKKTIFMQEDTNPLEKEALKQEFLPGTSSLIPGMPQQVPPSESAGQIDQNFKMPQEINYKEAFQHEVAHEMPPGSKSPF
-
Molecular Weight
45.21 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MGC16186 is a recombinant protein that has garnered attention in the field of molecular biology and biochemistry due to its potential role in various cellular processes. Originally identified as a novel gene, MGC16186 is believed to encode a protein involved in critical signaling pathways that regulate cell proliferation, differentiation, and apoptosis. Research on MGC16186 has primarily focused on its expression patterns across different tissues, suggesting its involvement in specific physiological functions. Given the rising interest in therapeutic applications, understanding the structure and function of MGC16186 is essential for elucidating its role in disease mechanisms, particularly in cancers and other proliferative disorders. Several studies have aimed at characterizing the protein through expression in various systems, analyzing its interactions with other biomolecules, and exploring its potential as a biomarker or therapeutic target. By leveraging advanced techniques such as protein crystallization and mass spectrometry, researchers hope to uncover the functional properties of MGC16186, paving the way for innovative interventions in disease treatment. The ongoing investigation into this recombinant protein not only enhances our understanding of its biological significance but also contributes to the broader field of protein research, with implications for drug discovery and therapeutic development.
